Skip to content
Open access · CC-BY via OpenAlex

Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease

Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi

Metabolites · 2021 · ▲ 108 citations

Abstract

Insulin resistance (IR) is defined as a lower-than-expected response to insulin action from target tissues, leading to the development of type 2 diabetes through the impairment of both glucose and lipid metabolism. IR is a common condition in subjects with nonalcoholic fatty liver disease (NAFLD) and is considered one of the main factors involved in the pathogenesis of nonalcoholic steatohepatitis (NASH) and in the progression of liver disease. The liver, the adipose tissue and the skeletal muscle are major contributors for the development and worsening of IR. In this review, we discuss the sites and mechanisms of insulin action and the IR-related impairment along the spectrum of NAFLD, from simple steatosis to progressive NASH and cirrhosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.3390/metabo11030155
Canonical
link ↗
Fetched
2026-06-29 MST

Cite this

APA
Armandi, A., Rosso, C., Caviglia, G.P., &amp; Bugianesi, E. (2021). Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. <em>Metabolites</em>. https://doi.org/10.3390/metabo11030155
Vancouver
Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites. 2021. doi:10.3390/metabo11030155.
BibTeX
@article{angelo2021Insuli, title = {Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease}, author = {Angelo Armandi and Chiara Rosso and Gian Paolo Caviglia and Elisabetta Bugianesi}, journal = {Metabolites}, year = {2021}, doi = {10.3390/metabo11030155}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings